FindTrial
Sign In

Evaluate the efficacy of Aragvadhadi Sutra in management of Bhagandar

Clinical Study to evaluate the efficacy of Aragvadhadi Sutra in management of Bhagandara with special reference to Fistula-in-ano - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108538
Enrollment
60
Registered
2026-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K60- Fissure and fistula of anal and rectal regions

Interventions

None listed

Sponsors

Chandra Shekhar Singh Ayurved Chikitsalay evam Shodh Kendra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical Signs and Symptoms of all types of Bhagandara.

Exclusion criteria

Exclusion criteria: HBsAg, HCV and HIV positive patients. Secondary fistula due to/along with: Ulcerative colitis Osteomyelitis of pelvic bones Crohn s disease Tuberculosis Uncontrolled Diabetes Pelvic abscess Carcinoma of rectum Hemorrhoids Fissure-in-ano Other systemic disorders.

Design outcomes

Primary

MeasureTime frame
Assessment of efficacy of Aragvadhadi Sutra in Bhagandara (Fistula-in-ano) based on Unit Cutting Time (U.C.T.) and complete healing of fistulous tractTimepoint: 4 weeks & 8 weeks—

Secondary

MeasureTime frame
Pain (Vedana) Discharge (Srava) Itching (Kandu) Burning Sensation (Daha) Inflammation (Shotha) Recurrence Rate IncontinenceTimepoint: 30 days—

Countries

India

Contacts

Public ContactDrManisha

Chandra Shekhar Singh Ayurvedic Sansthan kaushambi uttar pradesh

chhayakant.dash@gmail.com8249577732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026